Inhaled Corticosteroids Pediatric Growth Suppression Class Label Endorsed
Executive Summary
Precautions regarding pediatric growth suppression due to inhaled corticosteroid treatment of asthma should be addressed in class labeling, FDA's Pulmonary & Allergy Drugs and Endocrine & Metabolic Drugs Advisory Committees determined July 31 after a two-day joint meeting.